Goldfarb D A
Department of Urology, Cleveland Clinic Foundation, Ohio.
Urol Clin North Am. 1994 May;21(2):187-94.
The past decade has been considerable advances in basic knowledge of the renin-angiotensin system. Perhaps the most important new development has been the appreciation of a tissue-based renin-angiotensin system that can be independently regulated from the circulation. Greater insight into the mechanism by which the renin-angiotensin system exerts its actions has been achieved through the study of molecular biology and pharmacologic characterization of multiple angiotensin receptor subtypes. Ang II is now considered a growth promoter in cardiovascular tissues, and the resultant vascular hypertrophy is an important contributor to the maintenance of hypertension. Ang II also plays a role in the kidney, not only as a regulator of hemodynamics, but in the development of structural changes (hypertrophy, sclerosis), which are important in the pathogenesis of a variety of renal disorders. Finally, a central role for the renin-angiotensin system in experimental renovascular hypertension has been reaffirmed. In the future, basic knowledge and techniques of investigation gained from experimental models will be used to investigate clinical disorders such as hypertension and various renal disorders characterized by abnormal function of the renin-angiotensin system.
在过去十年中,肾素 - 血管紧张素系统的基础知识取得了长足的进展。或许最重要的新进展是认识到存在一种可独立于循环系统进行调节的组织型肾素 - 血管紧张素系统。通过对多种血管紧张素受体亚型的分子生物学研究和药理学特性分析,人们对肾素 - 血管紧张素系统发挥作用的机制有了更深入的了解。如今,血管紧张素II被认为是心血管组织中的生长促进剂,由此导致的血管肥大是维持高血压的重要因素。血管紧张素II在肾脏中也发挥作用,不仅作为血流动力学的调节因子,还参与结构变化(肥大、硬化)的发展,这些变化在各种肾脏疾病的发病机制中具有重要意义。最后,肾素 - 血管紧张素系统在实验性肾血管性高血压中的核心作用得到了再次确认。未来,从实验模型中获得的基础知识和研究技术将用于研究临床疾病,如高血压以及各种以肾素 - 血管紧张素系统功能异常为特征的肾脏疾病。